Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DURHAM, N.C., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on August 20, 2024, the Compensation Committee...
Pharmaceutical
IO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma
- Based on a per-protocol interim analysis of safety and efficacy data, the Independent Data Monitoring Committee (IDMC) recommended that...
Cold Chain Logistics Market total revenue is expected to reach USD 500.28 Bn by 2030 at a CAGR of 7.9 percent
Cold Chain Logistics Market was valued at USD 293.81 Bn. in 2023, and the total revenue is expected to grow...
Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
BOSTON, Aug. 30, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), which is building the leading platform for cell...
Quantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon.com so you can “own NOW and what’s NEXT”
TORONTO, ON / ACCESSWIRE / August 30, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical...
Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness
For the second year, Emergent is teaming up with pro football legend, Emmitt Smith, to educate communities on opioid risks...
CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
IRVINE, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on...
NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September
NAARDEN, The Netherlands and MIAMI, Aug. 30, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or...
Disc Medicine to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,...
iZafe Group Q2 Interim Report, April-June 20234
STOCKHOLM, SE / ACCESSWIRE / August 30, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB (publ.) presents today, August 30,...
Relief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update
RLF-TD011 investigator-initiated trial results for EB wound treatment anticipated in the coming weeksRLF-OD032 pilot PK study progresses with potential NDA...
Celly Nutrition Launches unbuzzd Grab-and-Go Stick Packs on Amazon.com so You Can “Own Now and What’s Next”
Vancouver, British Columbia--(Newsfile Corp. - August 29, 2024) - Celly Nutrition Corp. ("Celly Nutrition" or the "Company") proudly announces the...
BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results
Q2 2024 Revenue Increased 119% Year-over-Year to Over $6.0 Million, Exceeding Management Guidance Management Expects Third Quarter 2024 Revenues of...
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Presentation and live Q&A to take place Thursday, September 5, 2024, at 12 PM EDTMarlborough, Massachusetts--(Newsfile Corp. - August 29,...
Zomedica’s Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product
Assisi’s tPEMF™ technology aligns with Fear Free’s mission to “prevent and alleviate fear, anxiety, and stress in pets” ANN ARBOR, MI...
Inozyme Pharma to Participate at the 2024 Wells Fargo Healthcare Conference
BOSTON, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company...
ORYZON to Provide Corporate Progress Updates at Several Events in September
German Fall Conference 2024European College of Neuropsychopharmacology (ECNP) congress 2024Sachs Annual Biotech in Europe Forum 2024 MADRID, Spain and CAMBRIDGE,...
111, Inc. Announces Second Quarter 2024 Unaudited Financial Results
Maintained Operational Profitability for the Second Consecutive QuarterOperating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoYHeld Positive...
Activation Capital Selects 10 Startups for Inaugural Frontier BioHealth Program
Ten innovative life sciences and healthtech companies enter 16-week accelerator RICHMOND, Va., Aug. 28, 2024 /PRNewswire/ -- Activation Capital, an...
Veeva Announces Fiscal 2025 Second Quarter Results
Total Revenues of $676.2M, up 15% Year Over Year;Subscription Services Revenues of $561.3M, up 19% Year Over Year PLEASANTON, Calif.,...